GSK registry changes
Status changes, moved primary completion and completion dates, and results first posted on ClinicalTrials.gov, for trials linked to listed companies. Newest detection first.
Newest change detected Nov 18, 2026, 9:47 AM ET
| Detected | Trial | Change | Now | Before | Record updated |
|---|---|---|---|---|---|
| Nov 18, 2026, 9:47 AM ET | Completion date | Sep 30, 2026 (actual) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Primary completion date | Sep 30, 2026 (actual) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Completion date | May 3, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Primary completion date | May 3, 2027 (sponsor estimate) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Completion date | Oct 27, 2026 (actual) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Primary completion date | Oct 6, 2026 (actual) | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Completion date | Feb 6, 2030 (sponsor estimate) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Primary completion date | Mar 7, 2029 (sponsor estimate) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Completion date | Jun 4, 2029 (sponsor estimate) | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Primary completion date | Apr 2, 2029 (sponsor estimate) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Completion date | Apr 1, 2030 (sponsor estimate) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Primary completion date | Mar 13, 2030 (sponsor estimate) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Completion date | Aug 2027 (sponsor estimate) | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Primary completion date | Aug 6, 2026 (actual) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Completion date | Mar 2, 2029 (sponsor estimate) | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Completion date | Oct 8, 2029 (sponsor estimate) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Completion date | Aug 31, 2028 (sponsor estimate) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Primary completion date | Aug 31, 2028 (sponsor estimate) | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 12, 2026, 8:11 AM ET | Completion date | Feb 1, 2028 (sponsor estimate) | Locked | Locked |
- Detected Nov 18, 2026, 9:47 AM ETCompletion date
- Now
- Sep 30, 2026 (actual)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETPrimary completion date
- Now
- Sep 30, 2026 (actual)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatus
- Now
- Completed
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETCompletion dateNCT06702449A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy...GSK
- Now
- May 3, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETPrimary completion dateNCT06702449A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy...GSK
- Now
- May 3, 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatusNCT06702449A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy...GSK
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETCompletion dateNCT05263934Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With...GSK
- Now
- Oct 27, 2026 (actual)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETPrimary completion dateNCT05263934Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With...GSK
- Now
- Oct 6, 2026 (actual)
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatusNCT05263934Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With...GSK
- Now
- Completed
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETCompletion dateNCT07915791A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to...GSK
- Now
- Feb 6, 2030 (sponsor estimate)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETPrimary completion dateNCT07915791A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to...GSK
- Now
- Mar 7, 2029 (sponsor estimate)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETStatusNCT07915791A Study to Assess the Efficacy and Safety of Co-administration of GSK3862995B With GSK5784283 in Adult Participants With Moderate to...GSK
- Now
- Recruiting
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETStatus
- Now
- Recruiting
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETCompletion dateNCT07177339eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2...GSK
- Now
- Jun 4, 2029 (sponsor estimate)
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETPrimary completion dateNCT07177339eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2...GSK
- Now
- Apr 2, 2029 (sponsor estimate)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETCompletion dateNCT07740720A Study of the Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Locally...GSK
- Now
- Apr 1, 2030 (sponsor estimate)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETPrimary completion dateNCT07740720A Study of the Duration of Dostarlimab in Untreated Mismatch Repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) Locally...GSK
- Now
- Mar 13, 2030 (sponsor estimate)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETCompletion dateNCT04068753Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix CancerGSK
- Now
- Aug 2027 (sponsor estimate)
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETPrimary completion dateNCT04068753Niraparib in Combination With Dostarlimab in Patients With Recurrent or Progressive Cervix CancerGSK
- Now
- Aug 6, 2026 (actual)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETCompletion dateNCT06613698A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With...GSK
- Now
- Mar 2, 2029 (sponsor estimate)
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETCompletion dateNCT04246047Evaluation of Efficacy and Safety of Belantamab Mafodotin, Bortezomib and Dexamethasone Versus Daratumumab, Bortezomib and Dexamethasone...GSK
- Now
- Oct 8, 2029 (sponsor estimate)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETCompletion date
- Now
- Aug 31, 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETPrimary completion date
- Now
- Aug 31, 2028 (sponsor estimate)
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETStatus
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 12, 2026, 8:11 AM ETCompletion dateNCT06576271A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese...GSK
- Now
- Feb 1, 2028 (sponsor estimate)
- Before
- Locked
The previous value and the sponsor's record update date are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 changes. There are 6 more in this window; the full list is part of TrialScanner.
Unlock with TrialScannerTracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.
What is on this list
Changes Signal8 recorded between two refreshes of a trial's ClinicalTrials.gov record: status, primary completion and completion dates, and results first posted. A change is shown when it was detected, which can be days after the sponsor updated the record. Nothing here describes what a trial showed.
New registrations, enrollment, eligibility and outcome-measure edits are not recorded. A status change is the registry's own word for where the trial stands, and "results posted" means results were posted to the registry, never what they show.
Free readers see the first 25 changes of any filter with the new value. The previous value, the sponsor's record update date and later pages are part of the plan. See the methodology.